Recruiting OBSERVATIONAL NCT05097820

Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants

Sponsor: Groupe SEBBIN

Conditions Gender Dysphoria Orchitis Prosthesis Durability Testicular Agenesis Testicular Atrophy Testicular Cancer Testicular Torsion Undescended Testes

Interventions Placement of testicular prosthesis

Updated 6 times since 2021 Last updated: Sep 5, 2024 Started: Feb 5, 2021 Primary completion: Dec 31, 2030 Completion: Dec 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Gender Dysphoria and Orchitis, this trial is actively recruiting participants. The trial is conducted by Groupe SEBBIN and has accumulated 6 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Oct 2024 — Present [monthly]

Recruiting
Sep 2024 — Oct 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jan 2024 — Jul 2024 [monthly]

Recruiting
Jan 2023 — Jan 2024 [monthly]

Recruiting

▶ Show 1 earlier version

Nov 2021 — Jan 2023 [monthly]

Recruiting

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Groupe SEBBIN
University Hospital, Ghent

Data source: University Hospital, Ghent

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ghent, Belgium